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Organocatalyzed U-3CR of 4-oxoazetidine-2-carbaldehydes has been studied. Besides, it the 
organocatalyzed P-3CR of 4-oxoazetidine-2-carbaldehydes and azetidine-2,3-diones has been described 
for the first time. U-3CR and P-3CR adducts have been obtained in good yields and reasonable 
diastereoselectivities. Phenyl phosphinic acid has been the catalyst of choice to study the scope of both 
organocatalyzed multicomponent reactions using a variety of -lactams, isocyanides and amines. A 
catalytic cycle explaining the formation of Ugi and Passerini adducts has been proposed. Highly 
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functionalized U-3CR and P-3CR adducts derived from -lactams have proved to be useful substrates 
for the preparation of enantiopure -lactams and -lactones via N1C2 -lactam ring 
opening/cyclization under acidic or basic conditions. 
INTRODUCTION 
Multicomponent reactions (MCRs) are synthetic processes that combine three or more substrates to 
afford new compounds in one pot a single step.
1
 This powerful methodology allow allows both 
complexity and diversity in the final substrates with high atom economy. The advantages and the 
applications of MCRs have been widely demonstrated in the synthesis of natural products,
2,3
 and 
medicinal chemistry.
3,4 
 In particular, isocyanide-based MCRs (IMCRs) are especially attractive in terms 
of functional group tolerance and the high levels of chemo-, regio-, and stereoselectivity obtained.
5 
Among them, the Passerini three-component reaction (P-3CR) and the Ugi four-component reaction (U-
4CR) are the most prominent. In this context, List has reported the first organocatalyzed three-
component Ugi reaction (U-3CR) of different aldehydes, p-anisidine and a variety of isocyanides using 
phenyl phosphinic acid as catalyst.
6
 
On the other hand, the -lactam ring has been permanently associated with their potent antibacterial 
activity and, more recently, with enzyme inhibition, anticancer activity and gene activation.
7
 Besides, 
from the synthetic point of view, this four-membered ring is an excellent substrate to obtain a diverse 
family of nitrogenated compounds ranging from three-membered skeletons to macrocyclic structures 
and acyclic compounds.
8
 In particular, different methodologies which involves ring opening of the -
lactam nucleus followed by cyclization have been developed.
9
 
The -lactam ring is present in natural and synthetic products with interesting therapeutic 
activities.
10
 For example, succinimide
11
 and pyroglutamic acid
12
 cores have significant chemical and 
medicinal importance as they are implicate in different relevant processes. In addition, the -lactone 
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moiety is a substructure present in natural compounds. In particular N-acyl homoserine lactones (AHLs) 
are involved in the multicellular communication network of most gram-negative bacteria,
13
 and 
sesquiterpene lactones exhibit a variety of biological activities.
14
 
Following up our interest in the area of the synthesis of nitrogenated compounds,
15 
and the 
investigation of methodologies based in multicomponent processes,
16 
we became interested in the study 
of the organocatalyzed U-3CR process in -lactam substrates. 
RESULTS AND DISCUSSION 
U-3CR in of 4-Oxoazetidine-2-carbaldehydes 
First of all, we decided to investigate the U-3CR catalyzed by phenyl phosphinic acid in of 4-
oxoazetidine-2-carbaldehydes 1. 
Starting substrates, optically pure 4-oxoazetidine-2-carbaldehydes 1ae, were prepared, using 
standard methodology, as single cis-enantiomers from imines of (R)-2,3-O-
isopropylideneglyceraldehyde, through Staudinger reaction with the corresponding 
alkoxy(aryloxy)acetyl chloride in the presence of Et3N, followed by sequential acidic acetonide 
hydrolysis and oxidative cleavage.
17 
Our first experiment In order to show the viability of the organocatalyzed U-3CR in of -lactam 
aldehydes 1, our first experiment was the reaction of aldehyde 1a, allylamine and benzyl isocyanide 
(BnNC) in presence of a catalytic amount of phenyl phosphinic acid (10% mol) in catalytic amount 
(10% mol), using the same reaction conditions previously described previously (toluene, 80°C).
6
 In the 
event, -amino amide 2a was obtained as a separable mixture of syn/anti isomers in 61:39 ratio in 83% 
yield (Table 1, entry 1). Compound 2a was also obtained quantitatively within the same syn/anti ratio 
when the reaction was tested using under milder conditions, dichloromethane at room temperature 
compound 2a was obtained quantitatively in the same syn/anti ratio (Table 1, entry 2). Thus, the above 
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mild reaction conditions were applied to study the scope of the multicomponent process in of -lactam 
aldehydes 1. The reaction of aldehyde 1a, allylamine and t-butyl isocyanide (t-BuNC) in presence of 
phenyl phosphinic acid (10% mol) afforded product 2b with similar diastereoselectivity (63:37) and 
excellent yield (92%) (Table 1, entry 3). When the U-3CR was tested in aldehyde 1b, with an aliphatic 
substituent in the nitrogen, compound 2c was obtained with slightly better diastereoselectivity (72:28) in 
66% yield (Table 1, entry 4). Analogously, the reaction of aldehyde 1c, t-BuNC and methyl glycinate, 
afforded compound 2d with a comparable diastereoselectivity (70:30) and good yield (74%) (Table 1, 
entry 5). Unfortunately, -amino amide 2d was isolated as an inseparable mixture of syn/anti isomers. 
Next, we decided to explore the multicomponent reaction using aromatic amines. The reactions were 
performed using aldehydes 1a and 1d, with benzyl isocyanide and t-BuNC, respectively, and an electron 
rich aromatic amine, p-anisidine. Thus, compounds 2e and 2f were obtained with comparable values in 
terms of diastereoselectivity and yield (Table 1, entries 6 and 7). However, -(p-methoxyphenyl)amino 
amide 2e was isolated as an inseparable mixture of syn/anti isomers. Compound 2g was obtained 
without significant changes in terms of diastereoselectivity (68:32) and yield (67%) when the reaction 
was performed with aldehyde 1b, t-BuNC and an electron poor aromatic amine, such as p-nitroaniline, 
compound 2g was obtained with no significant changes in terms of diastereoselectivity (68:32) and yield 
(67%) (Table 1, entry 8). 
 
Table 1. U-3CR of 4-oxoazetidin-2-carbaldehydes 1, amines, isocyanides and phenyl phosphinic 
acid as catalyst
a
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Entry Aldehyde R
1
 R
2
 R
3
 R
4
 Conditions t (h)
b
 Product syn/anti
c
 Yield (%)
d
 
1 (+)-1a PMP
e
 MeO Bn 2-propenyl toluene/80°C 28 2a 61:39 51:32 
2 (+)-1a PMP
e
 MeO Bn 2-propenyl CH2Cl2/rt 28 2a 61:39 61:39 
3 (+)-1a PMP
e
 MeO t-Bu 2-propenyl CH2Cl2/rt 48 2b 63:37 58:34 
4 ()-1b 2-propenyl PhO Bn 2-propenyl CH2Cl2/rt 39 2c 72:28 48:18 
5 ()-1c Bn Phtf t-Bu CH2CO2Me
g
 CH2Cl2/rt 24 2d 70:30 74
h
 
6 (+)-1a PMP
e
 MeO t-Bu PMP
e
 CH2Cl2/rt 18 2e 64:36 74
h
 
7 ()-1d PMPe PhO Bn PMPe CH2Cl2/rt 16 2f 70:30 62:28 
8 ()-1b 2-propenyl PhO t-Bu PNPi CH2Cl2/rt 22 2g 68:32 46:21 
a
All reactions were performed by using an aldehyde/amine/isocyanide ratio of 1.0:1.1:1.1 mmol. 
b
Reaction progress was 
followed by TLC. 
c
The syn/anti ratio was determined by integration of well-resolved signals in the 
1
H NMR spectra (300 
MHz) of the crude reaction mixtures before purification.
 d
Yield of pure, isolated isomers with correct analytical and 
spectral data.
 e
PMP = 4-MeOC6H4.
 f
Pht = Phtalimidoyl.
 g
The reaction was carried out by treatment of amine chlorhydrate 
with triethyl amine in the reaction conditions.
 h
Yield of pure, isolated mixture of isomers.
 i
PNP = 4-NO2C6H4.  
Scheme 1 shows the mechanistic proposal for the U-3CR of compounds 1, which is comparable to 
List’s proposal. Phenyl phosphinic acid I can be considered a Brönsted acid and, in the form of its 
phenylphosphonous acid tautomer II, a Lewis base. Both properties must could be involved in the 
catalytic process. The mechanism proposed involves protonation of the in situ generated imine, formed 
by reaction of aldehyde 1 and the corresponding amine. Next, addition of the isocyanide and subsequent 
trapping of the nitrilium ion with the phosphinate anion would take place. Finally, a molecule of water, 
which is released in the imine formation, reacts with intermediate IV to generate V, which fragments to 
the -amino amide 2, and the catalyst. 
Scheme 1. Mechanistic proposal for the U-3CR catalyzed by phenyl phosphinic acid 
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P-3CR in of 4-Oxoazetidine-2-carbaldehydes and Azetidine-2,3-diones 
Once the U-3CR organocatalyzed by phenyl phosphinic acid was studied, we decided to investigate 
the analogous process, the Passerini reaction, in of aldehydes 1. In fact, to the best of our knowledge, 
there is no report about organocatalyzed diastereoselective Passerini reaction.
18
 
According with to the mechanism previously proposed for the organocatalyzed U-3CR, a molecule of 
water is formed during the formation of the imine. Thus, an external addition of water would be 
necessary which would act as the acidic component in the Passerini reaction  in the Passerini reaction it 
would be necessary an external addition of water which would act as the acidic component. Taking into 
account this idea, we decided to study the reaction of aldehyde 1a, t-BuNC, a stoichiometric amount of 
water and phenyl phosphinic acid (10% mol) in dichloromethane at room temperature. Fortunately, the 
corresponding -hydroxy amide 3a was obtained as a mixture of isomers (60:40) quantitatively (Table 
2, entry 1). Next, we decided to test the P-3CR in aqueous media in order to minimize the amount of 
organic solvent employed. However, adduct 3a was isolated in lower yield (64 and 67%) when the 
reaction was performed using mixtures of THF/H2O (1:1) and MeCN/H2O (1:1), respectively  adduct 3a 
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was isolated in lower yield (64 and 67%, respectively) (Table 2, entries 2 and 3). In addition, the 
reaction times for both experiments were considerably longer than longer than with the use of 
dichloromethane as solvent. In relation with the diastereoselectivity, the use of MeCN/H2O slightly 
decreased the syn/anti ratio (55:45) (Table 2, entry 3). Thus, we decide to study the scope of the reaction 
using dichloromethane as solvent at room temperature. When we the reaction was carried out the 
reaction with -lactam 1d, with containing a phenoxy instead instead of a methoxy group at C-3 
position of the -lactam ring, the diastereoselectivity was slightly increased (65:35) in the -hydroxy 
amide 3b (Table 2, entry 4). Next, we decided to investigate the effect of another isocyanide. Thus, the 
reaction of aldehyde 1a with BnNC, water and phenyl phosphinic acid, in the above reaction conditions 
afforded compound 3b with a comparable diastereoselectivity (60:40) and excellent yield (88%) (Table 
2, entry 5). 
Taking into consideration that the use of -lactam aldehydes 1 with aliphatic substituents at nitrogen 
position increased the diastereoselectivity in the U-3CR, we decided to examine the behaviour of 
aldehydes 1c and 1e. In the event, we observed that the reaction of both compounds with t-BuNC and 
phenyl phosphinic acid (10% mol) afforded adducts 3d and 3e respectively. Unexpectedly, compound 
3d was isolated in a very low diastereoselectivity (55:45) in 68% yield (Table 2, entry 6). Fortunately, 
compound 3e, which was isolated in excellent yield (96%), an improved diastereoselectivity was 
observed (70:30) (Table 2, entry 7). 
The structure of adducts 2 and 3 was assigned by NMR studies. The relative stereochemistry of 
compounds 2 has been established in the -lactams (see below). However, NMR vicinal coupling 
constants of the H4 and H4' protons for the syn-3 and anti-3 adducts are very useful information to 
determine stablish the relative stereochemistry (see Table S1 in Supporting information). For any pair of 
8 
 
 
diastereomers, the vicinal coupling constant between H4 and H4' is higher for anti-isomers (
3
JH4,H4' = 
5.21.6 Hz) than for the syn-isomers (3JH4,H4' = 3.41.2 Hz). In addition, the stereochemistry of 
compounds 3 was finally confirmed by chemical correlation with their corresponding -lactones (see 
below). Then, by analogy, adducts syn-2 are the major isomers for the previous U-3CR in aldehydes 1. 
The observed syn-diastereoselectivity for compounds 2 and 3 might be explained by the Felkin-Anh 
model.
19 
Table 2. P-3CR of 4-oxoazetidine-2-carbaldehydes 1, isocyanides and water in presence of phenyl 
Phosphinic Acid
a
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Entry Aldehyde R
1
 R
2
 R
3
 Solvent t (h)
b
 Product syn/anti
c
 Yield (%)
d
 
1 (+)-1a PMP
e
 MeO t-Bu CH2Cl2 21 3a 60:40 60:40 
2 (+)-1a PMP
e
 MeO t-Bu THF/H2O 48 3a 60:40 38:26 
3 (+)-1a PMP
e
 MeO t-Bu MeCN/H2O 32 3a 55:45 37:30 
4 ()-1d  PMPe PhO t-Bu CH2Cl2 19 3b 65:35 59:32 
5 ()-1a PMPe MeO Bn CH2Cl2 20 3c 60:40 55:35 
6 ()-1c Bn Phtf t-Bu CH2Cl2 21 3d 55:45 37:31 
7 (+)-1e 2-Propynyl PhO t-Bu CH2Cl2 20 3e 70:30 67:29 
a
All reactions were performed by using an aldehyde/isocyanide/water ratio of 1.0:1.1:1.1 mmol. 
b
Reaction progress was followed by TLC.
 c
The syn/anti ratio was determined by integration of well-
resolved signals in the 
1
H NMR spectra (300 MHz) of the crude reaction mixtures before purification.
 
d
Yield of pure, isolated isomers with correct analytical and spectral data.
 e
PMP = 4-MeOC6H4. 
 
The 3-substituted 3-hydroxy -lactam scaffold is an efficient carboxylate mimic,20 showing 
interesting activity in acyl CoA-cholesterol acyltransferase inhibition assays. In addition, it is found in 
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several monobactams with interesting pharmacological activities such as sulfacezin (A) (Figure 1), and 
related compounds. Due to the importance of the 3-hydroxy-3-substituted -lactam skeleton, we have 
reported the synthesis of these compounds using different synthetic strategies.
16,21 
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Figure 1. Sulfacezin (A), a representative example of a compound containing the 3-substituted 3-
hydroxy -lactam framework. 
The results obtained with oxoazetidine-2-carbaldehydes 1 encouraged us to screen the P-3CR in 
azetidine-2,3-diones 4.
 
The starting materials, enantiopure azetidine-2,3-diones 4, were efficiently 
prepared in optically pure form from aromatic or aliphatic (R)-2,3-O-isopropylideneglyceraldehyde-
derived imines by Staudinger reaction with acetoxyacetyl chloride in the presence of Et3N, followed by 
sequential transesterification and Swern oxidation, as we have previously reported.
22 
First, we examined the reaction of azetidine-2,3-dione 4a with BnNC, water and phenyl phosphinic 
acid (10% mol), affording -hydroxy amide 5a with complete syn-diastereoselectively (with cis 
configuration between the -lactam H4 and the amide group on C3) and good yield (78%). 
Analogously, the reaction of ketene 4b with BnNC and water, in the above reaction conditions afforded 
3-substituted 3-hydroxy--lactam 5b in excellent yield and total diastereoselectivity. The reaction of 
azetidine-2,3-diones 4a and 4d using t-BuNC afforded compounds 5c and 5d in total 
diastereoselectivity although, compound 5c was isolated in low yield. The use of ethyl isocyanoacetate 
with ketone 4a gave compound 5e with 45% yield and total diastereoselectivity. 
The diastereoselectivity must be is controlled by the presence of the substituent placed at C-4 
position of the -lactam ring, in which blocks preferentially one face of the carbonyl group is blocked. 
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Thus, the nucleophilic addition takes place to the less hindered face of the carbonyl group, affording P-
3CR adducts 3 as single isomers.
16a,
 
23 
Table 3. P-3CR of azetidine-2,3-diones 4, isocyanides and water in presence of phenyl phosphinic 
acid
a
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Entry Ketone R
1
 R
2
 t (h)
b
 Product syn/anti
c
 Yield (%)
d
 
1 (+)-4a PMP
e
 Bn 45 ()-5a 100:0 78 
2 ()-4b Bn Bn 27 ()-5b 100:0 80 
3 (+)-4a PMP
e
 t-Bu 48 ()-5c 100:0 48 
4 ()-4c  2-propenyl t-Bu 23 ()-5d 100:0 71 
5 ()-4a PMPe CH2CO2Et 72 (+)-5e 100:0 45 
a
All reactions were performed by using a ketone/isocyanide/water ratio of 1.0:1.1:1.1 
mmol. 
b
Reaction progress was followed by TLC. 
c
The syn/anti ratio was determined by 
integration of well-resolved signals in the 
1
H NMR spectra (300 MHz) of the crude 
reaction mixtures before purification. 
d
Yield of pure, isolated isomers with correct 
analytical and spectral data. 
e
PMP = 4-MeOC6H4. 
 
Synthesis of -Lactams and -Lactones via N1C2 Ring Cleavage/Cyclization of U-3CR Adduct 2 
and P-3CR Adduct 3, Respectively 
Taking into account the importance of -lactam and -lactone skeletons, we decide to take advantage 
of the highly functionalized adducts 2 and 3 to access to these 5-membered rings. In fact, rearrangement 
reactions of both adducts would result a stereoselective synthetic pathway to functionalized -lactams 6 
and -lactones 7 (Scheme 2). 
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Scheme 2. Possible N1C2 -lactam ring cleavage/cyclization of Ugi adducts 2 and Passerini 
adducts 3 
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N1C2 -lactam ring cleavage/cyclization can occur usually takes place in acidic or basic 
conditions. To explore the process, we decided to study the expansion reaction of compound syn-2a 
containing a p-methoxyphenyl group substituent in the nitrogen of the -lactam, was employed. It is 
well known that this kind of -lactams undergo easy N1C2 ring cleavage due to the stabilization of the 
nitrogen anion, acting as a good leaving group. Treatment of adduct syn-2a under acidic conditions, 
using a mixture of methanol and sulphuric acid, afforded -lactam syn-6a in low yield (22%) (Scheme 
3). 
Scheme 3. Synthesis of -lactam syn-6a via N1C2 cleavage/cyclization in acidic conditions 
N
O
MeO
H H
PMP
O
NHBn
NH
syn-(+)-2a
NO
MeO NHPMP
O
NHBn
syn-(+)-6a
MeOH/H2SO4
RT, 54 h
(22%)
 
In order to improve the yield, we decided to carry out the reaction in basic conditions, using a 
stoichiometric amount of sodium methoxide in methanol as solvent. Thus, reaction of compound syn-2a 
using one equivalent of sodium methoxide in methanol at room temperature exclusively afforded -
lactam syn-6a in excellent yield (84%) after chromatographic purification (Table 1, entry 1). The 
reaction of isomer anti-2a under the same reaction conditions gave the expected -lactam in 60% yield 
(Table 1, entry 2). Fortunately, the feasible epimerization of the proton in  position of the amide group 
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was not observed in both experiments. in both experiments it was not observed epimerization of the 
proton in  position of the amide group. The scope of the reaction was carried out developed using Ugi 
adducts syn-2b and anti-2b, with a t-butyl carbamoyl group, affording -lactams syn-6b and anti-6b in 
good yields (82 and 71%, respectively). Interestingly, the expansion process took place with Ugi 
adducts syn-2c and anti-2c with a propenyl group substituent in the nitrogen of the -lactam ring. -
Lactams syn-6c and anti-6c were obtained in excellent yields (81 and 76% respectively) in longer 
reaction times. It seems to be reasonable that the expansion reaction of N-propenyl substituted -lactams 
must can be slower than with N-PMP substituted -lactams, because the negative charge of the nitrogen 
is not in resonance with the aliphatic group. Next, we decided, to examine the influence of an aromatic 
substituent in the amine group, such as p-methoxyphenyl, was studied. Thus, reaction of an inseparable 
mixture of isomers 2e (syn:anti 64:36) in presence of sodium methoxide and methanol at 35°C, gave -
lactams syn-6d and anti-6d as a separable mixture of diastereoisomers by flash chromatography. 
Isomers syn-(+)-6d and anti-6d were isolated in good yields and in the same syn/anti ratio (Table 1, 
entry 7). -Lactam syn-6e was obtained in lower yield (45%) when the reaction was performed using 
compound syn-2f with a p-nitrophenyl group -lactam syn-6e was obtained in lower yield (45%). It 
seems reasonable that the nitrogen at this position is less nucleophile than in the rest of the examples. 
Table 4. Synthesis of -lactams 6 via N1C2 ring cleavage/cyclization of Ugi adducts 2a 
N
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Entry U-3CR adduct R
1
 R
2
 R
3
 R
4
 t(h)
b
 Product Yield (%)
c
 
1 syn-(+)-2a PMP
d
 MeO Bn 2-propenyl 10 syn-(+)-6a 84 
2 anti-()-2a PMPd MeO Bn 2-propenyl 10 anti-()-6a 60 
3 syn-(+)-2b PMP
d
 MeO t-Bu 2-propenyl 23 syn-(+)-6b 82 
4 anti-()-2b  PMPd MeO t-Bu 2-propenyl 23 anti-()-6b 71 
5 syn-()-2c 2-propenyl PhO Bn 2-propenyl 24 syn-(+)-6c 81 
6 anti-(+)-2c 2-propenyl PhO Bn 2-propenyl 24 anti-(+)-6c 76 
7
e
 2e
f
 PMP
d
 MeO t-Bu PMP
d
 17 syn-(+)-6d/anti-(+)-6d 51:28 
8
e
 syn-(+)-2f 2-propenyl PhO t-Bu PNP
g
 24 syn-(+)-6e 45 
a
All reactions were performed by using a substrate/MeONa ratio of 1.0:1.0 mmol. 
b
Reaction progress was 
followed by TLC. 
c
Yield of pure, isolated isomers with correct analytical and spectral data.
 d
PMP = 4-
MeOC6H4. 
e
The reaction was performed at 35°C. 
f
The starting material was an inseparable mixture of syn/anti 
isomers in 64:36 ratio. 
g
PNP = 4-NO2C6H4. 
 
Finally, it is important to mention remark that -lactams 6 with an amide group in C5 position, are 
structurally related to pyroglutamic acid. Thus, compounds 6 are interesting compounds from the 
chemical and biological point of view. 
Satisfied with the above results, we set out to evaluate the N1C2 ring cleavage/cyclization in of 
Passerini adducts 3. The application of this methodology would allow access to -butyrolactones 
(Tables 5 and 6). The FeCl3-catalyzed ring expansion reaction of 2-azetidinone-tethered allenic alcohols 
to give -lactones has been recently described in our research group in our research group we have 
described the ring expansion reaction of 2-azetidinone-tethered allenic alcohols catalyzed by iron(III) 
chloride to give -lactones.24 Thus, we decided to apply the same reaction conditions in to substrate syn-
3a. Reaction of -hydroxy amide syn-3a, with FeCl3·6H2O (10 % mol) in dichloroethane at 80 °C, 
selectively gave -lactone syn-7a selectively in very low yield (23%) (Table 5, entry 1). Then, we 
decided to try the basic conditions used for the preparation of -lactams 6. Reaction of compound syn-3a 
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with 1 equivalent of sodium methoxide gave a mixture of -lactone syn-7a (32%) and hydroxyamino 
ester 8 (47%) (Table 5, entry 2). The use of two equivalents of sodium methoxide at room temperature 
or under reflux conditions, afforded hydroxyamino ester 8 exclusively (75% and 48% respectively) 
(Table 5, entries 3 and 4). Unfortunately, the use of excess of sodium methoxide gave compound 8 in 
lower yield, with partial epimerization after long reaction times. Interestingly, when the reaction was 
conducted in a mixture of methanol and sulphuric acid gave hydroxyamino ester 8 in good yield (73%) 
after chromatographic purification (Table 5, entry 5). 
Table 5. Reactivity of -hydroxy amide syn-3a 
N
O
MeO
H H
PMP
O
NHtBu
OH
syn-(+)-3a
OO
MeO NHPMP
O
NHtBu
syn-(+)-7a
Conditions
MeO2C
MeO
NH
OH
O
NHtBu
PMP
()-8
+
 
Entry Conditions t(h)
a
 syn-(+)-7a/()-8b Yield (%)c 
1 FeCl3·6H2O (10% mol)/DCE/80 °C 21 100:0 23 
2 MeONa (1 equiv.)/MeOH/RT 6 40:60 32:47 
3 MeONa (2 equiv.)/MeOH/RT 3 0:100 75 
4 MeONa (1 equiv.)/MeOH/reflux 1 0:100 48 
5 MeOH (1 equiv.)/H2SO4 (2:1) 2 0:100 73 
a
Reaction progress was followed by TLC. 
b
The syn/anti ratio was determined by 
integration of well-resolved signals in the 
1
H NMR spectra (300 MHz) of the crude 
reaction mixtures before purification. 
c
Yield of pure, isolated isomers with correct 
analytical and spectral data. 
Due to the difficulties to obtain -lactones in a one pot process from -hydroxy amides 3, we 
decided to prepare these compounds via sequential ring opening followed by lactonization of the -
hydroxy amides 3 in acidic media. Thus, reaction of compound syn-3a in MeOH/H2SO4 (2:1) gave -
hydroxy amide 9 8. After neutralization and isolation of compound 9, The cyclization step was carried 
out using a catalytic amount of p-toluenesulfonic acid in toluene at reflux temperature after 
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neutralization and isolation of compound 8 9. In the event, enantiomerically pure -butyrolactone syn-7a 
was isolated in good yield (73%) without epimerization of the  position of the amide group (Table 6, 
entry 1). However, lactone anti-7a was obtained in low yield when the reaction was performed with 
isomer anti-3a, lactone anti-7a was obtained in low yield (Table 6, entry 2). To assess scope, Passerini 
adductsband 3c were tested as precursors. Gratifyingly, compounds 3band 3c were completely and 
exclusively converted to -lactones 7 in moderate yield (Table 6, entries 35). Replacement of the p-
methoxyphenyl group at the nitrogen, by an aliphatic substituent such as 2-propynyl group, in Passerini 
adduct syn-3d, also afforded -butyrolactone syn-7d (Table 6, entry 6). However, longer reaction time 
for the ring opening of the -lactam was observed. 
The structure and stereochemistry of -lactams 6 and -lactones 7 were assigned by NMR studies. 
The cis-stereochemistry of the four-membered ring was set during the cyclization step. The cyclic 
structures (by DEPT, HETCOR HMQC, and COSY) and the stereochemistry (by vicinal proton 
couplings) of -lactams 6 and -lactones 7 were established by NMR one- and two-dimensional 
techniques and NOESY-1D experiments (see Fig 1 in Supporting information). In addition, the vicinal 
coupling constants between H3, H4 and H4, H5 protons in compounds 6 are higher for anti,syn-isomers 
[(7.0 Hz < 
3
J3,4 < 9.5 Hz); (7.9 Hz < 
3
J4,5< 9.1 Hz)] than for the anti,anti-isomers [(7.0 Hz < 
3
J3,4 < 9.5 
Hz); (7.9 Hz < 
3
J4,5 < 9.1 Hz)] (see Table S3 in Supporting information). Analogously, for -lactones 7, 
the vicinal coupling constants between H3, H4 and H5, H4 protons, are higher for anti,syn-isomers [(5.7 
Hz < 
3
J3,4 < 6.9 Hz); (4.1 Hz < 
3
J5,4< 6.7 Hz)] than for the anti,anti-isomers [(4.9 Hz < 
3
J3,4 < 5.1 Hz); 
(4.7 Hz < 
3
J5,4< 5.4 Hz)] (see Table S4 in Supporting information). Taking into account that U-3CR 
adducts 2 and P-3CR adducts 3 are converted into -lactams 6 and -lactones 7, respectively, the 
stereochemistries of the carbinolic stereogenic centers for compounds 2 and 3 were confirmed by 
comparison with well-established five-membered rings 6 and 7. 
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Table 6. Synthesis of -butyrolactones 8 7 via sequential ring opening/lactonization of Passerini 
adducts 3 
N
O
R
2 H H
R
1
O
NHR
3
OH
syn-(+)-3
OO
R
2
NHR
1
O
NHR
3
syn-7
i) MeOH/H2SO4 (2:1)
ii) PTSA (20% mol), 
toluene, , 2h
N
O
R
2 H H
R
1
O
NHR
3
OH
anti-(+)-3
OO
R
2
NHR
1
O
NHR
3
anti-7
i) MeOH/H2SO4 (2:1)
ii) PTSA (20% mol), 
toluene, , 2h
3 4
4'
3 4
4'
3 4
5
3 4
5
 
Entry P-3CR adduct R
1
 R
2
 R
3
 t(h)
[a]
 Product Yield (%)
b
 
1 syn-(+)-3a PMP
c
 MeO t-Bu 2 syn-(+)-7a 73 
2 anti-()-3a PMPc MeO t-Bu 2 anti-()-7a 34 
3 syn-(+)-3b PMP
c
 MeO Bn 7 syn-(+)-7b 47 
4 anti-()-3b  PMPc MeO Bn 7 anti-()-7b 42 
5 syn-()-3c PMPc PhO t-Bu 24 syn-(+)-7c 57 
6 syn-(+)-3d 2-propynyl PhO t-Bu 72 syn-(+)-7d 52 
a
Reaction progress was followed by TLC for the methanolysis step. The reaction time for 
the lactonization reaction was 2 hours in all cases. 
b
Yield of pure, isolated isomers with 
correct analytical and spectral data. 

PMP = 4-MeOC6H4 
CONCLUSION 
In conclusion, firstly, organocatalyzed U-3CR between -lactam aldehydes, amines, isocyanides and 
phenyl phosphinic acid has been studied affording the corresponding adducts with moderate 
diastereoselectivities and good yields. Secondly, organocatalyzed P-3CR between carbonyl -lactams, 
isocyanides and water has been described for the fist time. The scope of these multicomponent 
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processes has been investigated and the utility of the resulting products for the selective preparation of 
highly functionalized -lactams and -lactones has been demonstrated. 
EXPERIMENTAL SECTION
25
 
General Methods. 
1
H and 
13
C NMR spectra were recorded in CDCl3 except otherwise stated. 
Chemical shifts are given in ppm relative to TMS (
1
H, 0.0 ppm) or CDCl3 (
13
C, 77.0 ppm). Low and 
high resolution mass spectra were performed on a QTOF LC/MS spectrometer using the electronic 
impact (EI) or electrospray modes (ES) unless otherwise stated. Specific rotation [α]D is given in 10
–1 
deg cm
2
 g
–1
 at 20 °C, and the concentration (c) is expressed in grams per 100 mL. All commercially 
available compounds were used without further purification. Flash S-2 chromatography was performed 
by using silica gel 60 (230−400 mesh). Products were identified by TLC. UV light (λ = 254nm) and a 
solution of phosphomolibdic acid in EtOH (1 g of phosphomolybdic acid hydrate, 100 mL EtOH) was 
used to develop the plates. 
General Procedure for the Organocatalyzed U-3CR of aldehydes 1. Synthesis of Compounds 2. 
Method A. To a solution of aldehyde 1 (1 mmol) in anhydrous dichloromethane (5 mL), the 
corresponding amine (1.1 mmol), the appropriate isocyanide (1.1 mmol) and phenyl phosphinic acid 
(0.1 mmol) were sequentially added at room temperature under argon atmosphere. The reaction mixture 
was stirred until complete disappearances of the starting material (TLC). Then, the solvent was removed 
under reduced pressure. The residue was purified by flash chromatography eluting with n-hexane/ethyl 
acetate mixtures. Method B. To a solution of aldehyde 1 (1 mmol) in anhydrous dichloromethane (5 
mL), methyl glycinate chlorhydrate (1.1 mmol) and triethylamine (1.1 mol) were added at room 
temperature. The reaction mixture was stirred at room temperature for 1 h. Then, t-butyl isocyanide (1.1 
mmol) and phenyl phosphinic acid (0.1 mmol) were added at room temperature and under argon 
atmosphere. The reaction mixture was stirred at room temperature for 14h. Then, the solvent was 
removed under reduced pressure. The residue was purified by flash chromatography. 
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Ugi adduct 2a. Method A. From 50 mg (1.19 mmol) of aldehyde (+)-1a, compound 2a was 
obtained as a mixture of isomers in a syn/anti ratio (61:39). After flash chromatography (n-hexane/ethyl 
acetate, 1:1) 53 mg (61%) of the less polar compound syn-(+)-2a and 34 mg (39%) of the more polar 
compound anti-(+)-2a were obtained. syn-(+)-2a. White solid; Mp: 9495°C (n-hexane/ethyl acetate); 
[]D +66.0 (c 0.3, CHCl3); 
1
H NMR (300 MHz, CDCl3, 25°C):  = 7.88 (t, J = 5.3 Hz, 1H), 7.26 (m, 
5H), 7.12 (m, 2H), 6.73 (AA'XX', 2H), 5.74 (m, 1H), 5.08 (m, 2H), 5.00 (dd, J = 5.3 Hz, J = 1.3 Hz, 
1H), 4.68 (d, J = 5.3 Hz, 1H), 4.47 (dd, J = 14.8, 6.3 Hz, 1H), 4.19 (dd, J = 14.8, 5.5 Hz, 1H), 3.74 (s, 
3H), 3.65 (s, 3H), 3.40 (s, 1H), 3.29 (dd, J = 13.8, 6.4 Hz, 1H), 3.20 (dd, J = 13.7, 6.0 Hz, 1H); 
13
C 
NMR (75 MHz, CDCl3, 25°C):  = 172.8, 164.8, 156.7, 137.6, 135.7, 130.1, 128.6, 127.6, 127.4, 119.3, 
117.0, 114.2, 83.2, 59.9, 59.2, 58.8, 55.4, 51.5, 43.3; IR (KBr):  = 3340, 1749, 1663 cm–1; HRMS 
(ES): calcd (%) for C23H28N3O4
+
 [M+H]
+
: 410.2074; found: 410.2068. anti-(+)-2a. Colorless oil; []D 
+123.2 (c 0.4, CHCl3); 1H NMR (300 MHz, CDCl3, 25°C):  = 8.14 (t, J = 5.6 Hz, 1H), 7.40 (AA'XX', 
2H), 7.30 (m, 5H), 6.91 (AA'XX', 2H), 5.70 (m, 1H), 5.11 (dd, J = 5.0, 3.7 Hz, 1H), 4.84 (m, 2H), 4.69 
(d, J = 5.1 Hz, 1H), 4.57 (dd, J = 14.9, 6.7 Hz, 1H), 4.34 (dd, J = 15.0, 5.3 Hz, 1H), 3.90 (d, J = 3.6 Hz, 
1H), 3.81 (s, 3H), 3.47 (s, 3H), 3.24 (dd, J = 13.9, 5.4 Hz, 1H), 2.89 (dd, J = 13.9, 7.0 Hz, 1H); 
13
C 
NMR (75 MHz, CDCl3, 25°C):  = 172.0, 164.4, 156.6, 138.3, 135.9, 130.6, 128.6, 127.5, 127.3, 118.4, 
117.3, 114.6, 83.8, 60.0, 58.6, 57.0, 55.4, 51.2, 43.0; IR (CHCl3):  = 3346, 1748, 1659 cm
–1
; HRMS 
(ES): calcd (%) for C23H28N3O4
+
 [M+H]
+
: 410.2074; found: 410.2076. 
Ugi adduct 2b. Method A. From 60 mg (0.26 mmol) of aldehyde (+)-1a, compound 2b was 
obtained as a mixture of isomers in a syn/anti ratio (63:37). After flash chromatography (n-hexane/ethyl 
acetate, 1:3) 33 mg (34%) of the less polar compound syn-(+)-2b and 55 mg (58%) of the more polar 
compound anti-(+)-2a were obtained. syn-(+)-2b. Colorless oil; []D +85.5 (c 0.7, CHCl3); 
1
H NMR 
(300 MHz, CDCl3, 25°C):  = 7.66 (bs, 1H), 7.38 (AA'XX', 2H), 6.88 (AA'XX', 2H), 5.63 (m, 1H), 5.02 
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(dd, J = 5.1, 3.6 Hz, 1H), 4.87 (m, 2H), 4.67 (d, J = 5.2 Hz, 1H), 3.79 (s, 3H), 3.72 (d, J = 3.4 Hz, 1H), 
3.55 (s, 3H), 3.23 (ddt, J = 14.1, 5.4 Hz,
 
1.5 Hz, 1H), 2.88 (dd, J = 14.2, 6.7 Hz, 1H), 1.34 (s, 9H); 
13
C 
NMR (75 MHz, CDCl3, 25°C):  = 171.1, 164.4, 156.5, 136.1, 130.7, 118.4, 116.8, 114.5, 83.8, 60.1, 
58.9, 57.6, 55.4, 51.3, 50.6, 28.6; IR (CHCl3):  = 3339, 1749, 1666 cm
–1
; HRMS (ES): calcd (%) for 
C20H30N3O4
+
 [M+H]
+
: 376.2231; found: 376.2244. anti-(+)-2b. Colorless oil; []D +70.7 (c 0.6, 
CHCl3); 
1
H NMR (300 MHz, CDCl3, 25°C):  = 7.50 (bs, 1H), 7.30 (AA'XX', 2H), 6.82 (AA'XX', 2H), 
5.80 (m, 1H), 5.12 (m, 2H), 4.98 (d, J = 5.1 Hz, 1H), 4.66 (d, J = 5.2 Hz, 1H), 3.78 (3H, s), 3.65 (s, 3H), 
3.36 (dd, J = 14.0, 6.2 Hz, 1H), 3.20 (bs, 1H), 3.17 (dd, J = 14.3, 6.0 Hz, 1H), 1.29 (s, 9H); 
13
C NMR 
(75 MHz, CDCl3, 25°C):  = 171.6, 165.1, 156.8, 136.0, 130.4, 119.6, 116.7, 114.3, 83.2, 59.9, 59.5, 
58.7, 55.5, 51.4, 28.4, 50.6; IR (CHCl3):  = 3332, 1750, 1668 cm
–1
; HRMS (ES): calcd (%) for 
C20H30N3O4
+
 [M+H]
+
: 376.2231; found: 376.2234. 
Ugi adduct 2c. Method A. From 50 mg (0.22 mmol) of aldehyde ()-1b, compound 2c was 
obtained as a mixture of isomers in a syn/anti ratio (72:28). After flash chromatography (CH2Cl2/ethyl 
acetate, 3:1) 42 mg (48%) of the less polar compound syn-(+)-2c and 16 mg (18%) of the more polar 
compound anti-(+)-2c were obtained. syn-(+)-2c. White solid. Mp: 108109°C (n-hexane/ethyl acetate); 
[]D +17.4 (c 0.6, CHCl3); 
1
H NMR (300 MHz, CDCl3, 25°C):  = 7.74 (bs, 1H), 7.30 (m, 7H), 7.04 (m, 
3H), 5.74 (m, 2H), 5.30 (d,
 
J = 4.9 Hz, 1H), 5.12 (m, 4H), 4.54 (dd, J = 4.9, 3.0 Hz, 1H), 4.41 (d,
 
J = 6.0 
Hz, 2H), 4.07 (ddt, J = 15.4, 5.6 Hz, 1.4 Hz, 1H), 3.60 (dd, J = 15.4, 7.0 Hz, 1H), 3.40 (d,
 
J = 2.9 Hz, 
1H), 3.25 (d,
 
J = 6.2 Hz, 2H); 
13
C NMR (75 MHz, CDCl3, 25°C):  = 171.8, 165.6, 157.3, 137.7, 135.5, 
130.7, 129.7, 128.7, 127.8, 127.6, 122.6, 119.2, 117.1, 115.4, 80.8, 60.3, 59.0, 51.4, 44.4, 43.4; IR 
(CHCl3):  = 3319, 1757, 1656 cm
–1
; HRMS (ES): calcd (%) for C24H28N3O3
+
 [M+H]
+
: 406.2125; 
found: 406.2106. anti-(+)-2c. White solid. Mp: 125126°C (n-hexane/ethyl acetate); []D +50.7 (c 0.4, 
CHCl3); 
1
H NMR (300 MHz, CDCl3, 25°C):  = 7.77 (t, J = 5.5 Hz, 1H), 7.29 (m, 5H), 7.17 (m, 2H), 
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7.03 (m, 3H), 5.79 (m, 2H), 5.33 (d,
 
J = 4.9 Hz, 1H), 5.21 (m, 4H), 4.61 (t, J = 4.9 Hz, 1H), 4.40 (dd, J 
= 14.2, 6.3 Hz, 1H), 4.25 (ddt, J = 15.4, 5.4, 1.4 Hz, 1H), 4.11 (dd,
 
J = 14.8, 5.6 Hz, 1H), 3.65 (d, J = 
4.8 Hz, 1H), 3.63 (dd, J = 15.2, 7.4 Hz, 1H), 3.38 (dd, J = 13.9, 6.0 Hz, 1H), 3.25 (dd. J =13.9, 6.2 Hz, 
1H); 
13
C NMR (75 MHz, CDCl3, 25°C):  = 171.0, 165.7, 157.2, 137.8, 135.7, 130.6, 129.6, 128.6, 
127.7, 127.4, 122.7, 119.8, 117.3, 115.6, 81.1, 59.9, 58.9, 51.7, 43.7, 43.2; IR (CHCl3):  = 3332, 1755, 
1658 cm
–1
; HRMS (ES): calcd (%) for C24H28N3O3
+
 [M+H]
+
: 406.2125; found: 406.2121. 
Ugi adduct 2d. Method B. From 89 mg (0.27 mmol) of aldehyde ()-1c, compound 2d was 
obtained as a mixture of isomers in a syn/anti ratio (70:30). After flash chromatography (n-hexane/ethyl 
acetate, 1:3) 100 mg (74%) of an inseparable mixture of isomers syn-2d and anti-2d was obtained. syn-
2d. 
1
H NMR (300 MHz, CDCl3, 25°C):  = 7.86 (AA'BB', 2H), 7.74 (AA'BB', 2H), 7.33 (m, 5H), 6.24 
(bs, 1H), 5.45 (d, J = 5.3 Hz, 1H), 4.73 (d, J = 15.2 Hz, 1H), 4.60 (d, J = 15.2 Hz, 1H), 4.04 (dd, J = 7.8, 
5.3 Hz, 1H), 3.64 (s, 3H), 3.29 (d, J = 7.9 Hz, 1H), 3.09 (d, J = 17.2 Hz, 1H), 2.97 (d, J = 17.1 Hz, 1H), 
2.03 (bs, 1H), 1.00 (s, 9H); 
13
C NMR (75 MHz, CDCl3, 25°C):  = 171.7, 169.4, 164.6, 135.8, 134.5, 
131.9, 128.9, 128.2, 127.9, 123.7, 62.9, 59.6, 55.6, 51.8, 51.0, 48.0, 46.1, 28.2; HRMS (ES): calcd (%) 
for C27H30N4O6
+
 [M+H]
+
: 507.2238; found: 507.2255. anti-2d. 
1
H NMR (300 MHz, CDCl3, 25°C):  = 
7.86 (2H, AA'BB'), 7.74 (AA'BB', 2H), 7.33 (m, 5H), 6.49 (bs, 1H), 5.37 (d, J = 5.3 Hz, 1H), 4.68 (d, J = 
15.2 Hz, 1H), 4.40 (d, J = 15.0 Hz, 1H), 4.11 (dd, J = 6.9, 5.4 Hz, 1H), 3.45 (s, 3H), 3.26 (d, J = 7.2 Hz, 
1H), 3.00 (d, J = 17.2 Hz, 1H), 2.85 (d, J = 17.4 Hz, 1H), 2.03 (bs, 1H), 1.13 (s, 9H); 
13
C NMR (75 
MHz, CDCl3, 25°C):  = 171.4, 167.4, 164.3, 135.5, 134.4, 131.9, 129.0, 128.3, 128.0, 123.7, 61.8, 
58.7, 56.4, 51.6, 51.1, 48.4, 45.6, 28.3. 
Ugi adduct 2e. Method A. From 50 mg (0.21 mmol) of aldehyde ()-1a, compound 2e was 
obtained as a mixture of isomers in a syn/anti ratio (64:36). After flash chromatography (n-hexane/ethyl 
acetate, 1:1) 70 mg (74%) of an inseparable mixture of isomers syn-2e and anti-2e was obtained. syn-2e. 
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1
H NMR (300 MHz, CDCl3, 25°C):  = 7.12 (m, 2H), 7.09 (AA'XX', 2H), 6.68 (AA´XX´, 2H), 6.58 (m, 
2H), 5.19 (bs, 1H), 4.76 (d, J = 5.1 Hz, 1H), 4.44 (d, J = 2.6 Hz, 1H), 3.74 (s, 3H), 3.671 (s, 3H), 3.669 
(s, 3H), 1.36 (s, 9H); 
13
C NMR (75 MHz, CDCl3, 25°C):  = 170.0, 163.6, 156.2, 153.1, 140.2, 130.0, 
118.5, 115.9, 114.5, 113.9, 83.7, 60.3, 58.9, 57.9, 55.6, 55.3, 51.0, 28.6. HRMS (ES): calcd (%) for 
C24H31N3O5
+
 [M+H]
+
: 442.2336; found: 442.2336. anti-2e. 
1
H NMR (300 MHz, CDCl3, 25°C):  = 
7.38 (AA'XX', 2H), 6.85 (AA'XX', 2H), 6.77 (AA'XX', 2H), 6.58 (m, 2H), 5.09 (dd, J = 5.2, 1.7 Hz, 1H), 
4.68 (d, J = 5.3 Hz, 1H), 3.79 (s, 3H), 3.76 (s, 3H), 3.67 (m, 1H), 3.43 (s, 3H), 1.28 (s, 9H); 
13
C NMR 
(75 MHz, CDCl3, 25°C):  = 171.0, 165.1, 156.8, 153.3, 140.6, 130.1, 119.5, 115.8, 114.5, 114.3, 82.9, 
59.5, 58.2, 59.0, 55.5, 55.4, 51.0, 28.3. 
Ugi adduct 2f. Method A. From 53 mg (0.14 mmol) of aldehyde ()-1d, compound 2f was obtained 
as a mixture of isomers in a syn/anti ratio (70:30). After flash chromatography (n-hexane/ethyl acetate, 
1:1) 21 mg (28%) of the less polar compound anti-(+)-2f and 50 mg (64%) of the more polar compound 
syn-(+)-2f were obtained. syn-(+)-2f. White solid. Mp: 141143°C (n-hexane/ethyl acetate); []D +82.7 
(c 0.6, CHCl3); 
1
H NMR (300 MHz, CDCl3, 25°C):  = 7.55 (t, J = 5.6 Hz, 1H), 7.30 (m, 5H), 7.08 (m, 
7H), 6.69 (AA'XX', 2H), 6.51 (AA'XX', 2H), 6.47 (AA'XX', 2H), 5.51 (d,
 
J = 5.0 Hz, 1H), 5.40 (dd, J = 
4.8, 3.5 Hz, 1H), 4.72 (d, J = 3.4 Hz, 1H), 4.34 (dd, J = 14.5, 5.6 Hz, 1H), 4.34 (dd, J = 14.5, 5.6 Hz, 
1H), 4.20 (dd, J = 14.6, 6.0 Hz, 1H), 3.65 (s, 3H), 3.74 (s, 3H); 
13
C NMR (75 MHz, CDCl3, 25°C):  = 
170.6, 162.2, 157.2, 156.6, 153.4, 140.1, 137.6, 129.7, 129.6, 128.7, 127.8, 127.5, 123.1, 118.8, 116.2, 
116.1, 114.6, 114.2, 81.1, 58.2, 59.0, 55.6, 55.4, 43.4; IR (KBr):  = 3374, 1750, 1661 cm–1; HRMS 
(ES): calcd (%) for C32H32N3O5
+
 [M+H]
+
: 538.2336; found: 538.2311. anti-(+)-2f. White solid. Mp: 
150151°C (n-hexane/ethyl acetate); []D +66.2 (c 0.2, CHCl3); 
1
H NMR (300 MHz, CDCl3, 25°C):  = 
7.59 (t, J = 5.6 Hz, 1H), 7.36 (AA'XX', 2H), 7.25 (m, 3H), 7.19 (t, J = 8.0 Hz, 2H), 7.08 (m, 2H), 6.96 (t, 
J = 7.3 Hz, 1H), 6.77 (d, J = 8.8 Hz, 2H), 6.74 (AA'XX', 2H), 6.65 (AA'XX', 2H), 6.57 (AA'XX', 2H), 
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5.53 (d,
 
J = 5.1 Hz, 1H), 5.43 (d, J = 5.3 Hz, 1H), 4.44 (dd, J = 14.8, 6.3 Hz, 1H), 4.36 (dd, J = 14.9, 5.7 
Hz, 1H), 4.08 (s, 1H), 3.77 (s, 3H), 3.75 (s, 3H); 
13
C NMR (75 MHz, CDCl3, 25°C):  = 172.1, 163.4, 
157.1, 156.8, 153.7, 140.5, 137.4, 129.9, 129.5, 128.6, 127.8, 127.5, 122.3, 119.3, 116.1, 115.1, 114.8, 
114.6, 79.3, 58.44, 58.42, 55.8, 55.5, 43.6; IR (KBr):  = 3350, 1754, 1664 cm–1; HRMS (ES): calcd 
(%) for C32H32N3O5
+
 [M+H]
+
: 538.2336; found: 538.2317. 
Ugi adduct 2g. Method A. From 58 mg (0.25 mmol) of aldehyde ()-1b, compound 2g was 
obtained as a mixture of isomers in a syn/anti ratio (68:32). After flash chromatography (diethyl ether) 
24 mg (21%) of the less polar compound anti-(+)-2g and 52 mg (46%) of the more polar compound syn-
(+)-2g were obtained. syn-(+)-2g. Yellowish solid. Mp: 193194°C (n-hexane/ethyl acetate); []D +5.8 
(c 1.0, CHCl3); 
1
H NMR (300 MHz, CDCl3, 25°C):  = 8.11 (AA'XX', 2H), 7.25 (m, 2H), 7.02 (m, 1H), 
6.88 (m, 2H), 6.67 (AA'XX', 2H), 6.51 (bs, 1H), 5.77 (m, 1H), 5.39 (d, J = 5.1 Hz, 1H), 5.25 (m, 3H), 
4.56 (t, J = 5.0 Hz, 1H), 4.21(dd, J = 6.3, 5.3 Hz, 1H), 4.15 (ddt, J = 15.3, 5.6, 1.2 Hz, 1H), 3.51 (dd, J = 
15.3, 7.2 Hz, 1H), 1.32 (s, 9H); 
13
C NMR (75 MHz, CDCl3, 25°C):  = 168.1, 165.9, 156.5, 152.0, 
139.8, 130.4, 129.7, 126.1, 122.8, 120.1, 115.1, 112.8, 80.1, 58.0, 57.1, 51.8, 44.5, 28.5; IR (KBr):  = 
3301, 1755 cm
–1
; HRMS (ES): calcd (%) for C24H28N4O5
+
 [M+H]
+
: 453.2132; found: 453.2133. 
anti-(+)-2g. Yellowish solid. Mp: 189190°C (n-hexane/ethyl acetate); []D +63.4 (c 0.1, CHCl3) 
1
H 
NMR (300 MHz, CDCl3, 25°C):  = 8.15 (AA'XX', 2H), 7.39 (m, 2H), 7.14 (m, 3H), 6.62 (AA'XX', 2H), 
6.58 (bs, 1H), 5.60 (m, 2H), 5.43 (d, J = 5.0 Hz, 1H), 5.19 (m, 2H), 4.59 (dd, J = 5.0, 2.6 Hz, 1H), 4.43 
(dd, J = 7.8, 2.6 Hz, 1H), 4.03 (ddt, J = 15.4, 5.7, 1.3 Hz, 1H), 3.55 (dd, J = 15.3, 7.2 Hz, 1H), 1.29 (s, 
9H); 
13
C NMR (75 MHz, CDCl3, 25°C):  = 166.7, 165.0, 156.6, 151.2, 139.8, 130.4, 130.0, 126.5, 
123.6, 120.2, 115.8, 112.2, 81.0, 58.3, 56.3, 51.8, 43.8, 28.5; IR (KBr):  = 3300, 1761 cm–1; HRMS 
(ES): calcd (%) for C24H28N4O5
+
 [M+H]
+
: 453.2132; found: 453.2126. 
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General Procedure for the Organocatalyzed P-3CR of aldehydes 1. Synthesis of Compounds 3. 
To a solution of aldehyde 1 (1 mmol) in anhydrous dichloromethane (5 mL), water (1.1 mmol), the 
appropriate isocyanide (1.1 mmol) and phenyl phosphinic acid (0.1 mmol) were sequentially added at 
room temperature under argon atmosphere. The reaction mixture was stirred until complete 
disappearances of the starting material (TLC). Then, the solvent was removed under reduced pressure. 
The residue was purified by flash chromatography eluting with n-hexane/ethyl acetate mixtures. 
Passerini adduct 3a. From 100 mg (0.42 mmol) of aldehyde ()-1a, compound 3a was obtained as 
a mixture of isomers in a syn/anti ratio (60:40). After flash chromatography (n-hexane/ethyl acetate, 
1:2) 57 mg (40%) of the less polar compound anti-(+)-3a and 86 mg (60%) of the more polar compound 
syn-(+)-3a were obtained. syn-(+)-3a. White solid. Mp: 116117°C (n-hexane/ethyl acetate); []D +45.2 
(c 0.2, CHCl3). 
1
H NMR (300 MHz, CDCl3, 25°C):  = 7.40 (AA'XX, 2H,), 6.80 (AA'XX', 2H), 6.59 (bs, 
1H), 4.94 (dd, J = 5.2, 1.2 Hz, 1H), 4.71 (d,
 
J = 5.2 Hz, 1H), 4.27 (d, J = 1.2 Hz, 1H), 3.76 (s, 3H), 3.70 
(s, 3H), 1.22 (s, 9H); 
13
C NMR (75 MHz, CDCl3, 25°C):  = 169.2, 164.2, 156.7, 130.2, 120.0, 114.2, 
82.8, 69.2, 60.0, 58.2, 55.4, 50.9, 28.4; IR (KBr):  = 3394, 1747 cm–1; HRMS (ES): calcd (%) for 
C17H25N2O5
+
 [M+H]
+
: 337.1758; found: 337.1765. anti-(+)-3a. White solid. Mp: 158159°C (n-
hexane/ethyl acetate); []D +83.9 (c 0.4, CHCl3). 
1
H NMR (300 MHz, CDCl3, 25°C):  = 7.41 (AA'XX', 
2H), 6.83 (m, 1H), 6.85 (AA'XX', 2H), 4.80 (dd, J = 5.2, 1.6 Hz, 1H), 4.73 (d, J = 5.2 Hz, 1H), 4.48 (d, J 
= 1.1 Hz, 1H), 3.87 (bs, 1H), 3.78 (s, 3H), 3.69 (s, 3H), 1.33 (s, 9H); 
13
C NMR (75 MHz, CDCl3, 25°C): 
 = 169.4, 163.5, 156.6, 130.2, 118.9, 114.4, 83.2, 68.8, 60.0, 59.5, 55.4, 51.4, 28.6; IR (KBr):  = 3393, 
1747, 1664 cm
–1
; HRMS (ES): calcd (%) for C17H25N2O5
+
 [M+H]
+
: 337.1758; found: 337.1757. 
Passerini adduct 3b. From 67 mg (0.22 mmol) of aldehyde ()-1a, compound 3b was obtained as a 
mixture of isomers in a syn/anti ratio (65:35). After flash chromatography (n-hexane/ethyl acetate, 1:1) 
53 mg (59%) of the less polar compound syn-(+)-3b and 29 mg (32%) of the more polar compound 
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anti-(+)-3b were obtained. syn-(+)-3b. White solid; Mp: 167169°C (n-hexane/ethyl acetate); []D 
+72.5 (c 1.4, CHCl3). 
1
H NMR (300 MHz, CDCl3, 25°C):  = 7.45 (AA'XX', 2H), 7.34 (m, 2H), 7.06 
(m, 3H), 6.83 (AA'XX', 2H), 6.64 (bs, 1H), 5.45 (d,
 
J = 5.1 Hz, 1H), 5.20 (d, J = 5.6 Hz, 1H), 4.41 (d, J 
= 4.0 Hz, 1H), 3.78 (s, 3H), 3.13 (d, J = 4.2 Hz, 1H), 1.25 (s, 9H); 
13
C NMR (75 MHz, CDCl3, 25°C):  
= 169.2, 162.7, 156.9, 156.8, 130.2, 129.9, 123.2, 120.0, 115.9, 114.3, 80.1, 68.8, 58.5, 55.4, 51.0, 28.4; 
IR (KBr):  = 3390, 1751, 1664 cm–1; HRMS (ES): calcd (%) for C22H27N2O5
+
 [M+H]
+
: 399.1914; 
found: 399.1927. anti-(+)-3b. White solid; Mp: 127128°C (n-hexane/ethyl acetate); []D +108.2 (c 
0.6, CHCl3). 
1
H NMR (300 MHz, CDCl3, 25°C):  = 7.47 (AA'XX', 2H), 7.35 (m, 2H), 7.12 (m, 3H), 
6.88 (AA'XX', 2H), 6.76 (bs, 1H), 5.48 (d,
 
J = 5.3 Hz, 1H), 5.00 (dd, J = 5.3, 1.8 Hz, 1H), 4.61 (s, 1H), 
3.79 (s, 3H), 1.26 (s, 9H); 
13
C NMR (75 MHz, CDCl3, 25°C):  = 168.8, 162.2, 156.8, 156.7, 130.0, 
129.9, 123.5, 119.0, 116.0, 114.4, 80.4, 68.8, 59.9, 55.4, 51.5, 28.5; IR (KBr):  = 3384, 1752, 1656 cm–
1
; HRMS (ES): calcd (%) for C22H27N2O5
+
 [M+H]
+
: 399.1914; found: 399.1897. 
Passerini adduct 3c. From 103 mg (0.44 mmol) of aldehyde ()-1a, compound 3c was obtained as 
a mixture of isomers in a syn/anti ratio (60:40). After flash chromatography (n-hexane/ethyl acetate, 
1:2) 57 mg (35%) of the less polar compound anti-(+)-3c and 86 mg (53%) of the more polar compound 
syn-(+)-3c were obtained. syn-(+)-3c. White solid; Mp: 157159°C (n-hexane/ethyl acetate); []D +67.3 
(c 0.5, CHCl3). 
1
H NMR (300 MHz, CDCl3, 25°C):  = 7.45 (AA'XX', 2H), 7.34 (m, 2H), 7.06 (m, 3H), 
6.83 (AA'XX', 2H), 6.64 (bs, 1H), 5.45 (d,
 
J = 5.1 Hz, 1H), 5.20 (d, J = 5.6 Hz, 1H), 4.41 (d, J = 4.0 Hz, 
1H), 3.78 (s, 3H), 3.13 (d, J = 4.2 Hz, 1H), 1.25 (s, 9H); 
13
C NMR (75 MHz, CDCl3, 25°C):  = 169.2, 
162.7, 156.9, 156.8, 130.2, 129.9, 123.2, 120.0, 115.9, 114.3, 68.8, 58.5, 55.4, 51.0, 28.4; IR (KBr):  = 
3295, 1732, 1652 cm
–1
; HRMS (ES): calcd (%) for C20H23N2O5
+
 [M+H]
+
: 371.1601; found: 371.1608. 
anti-(+)-3c. White solid; Mp: 135136°C (n-hexane/ethyl acetate); []D +107.6 (c 0.5, CHCl3). 
1
H 
NMR (300 MHz, CDCl3, 25°C):  = 7.39 (AA'XX', 2H), 7.30 (m, 5H), 7.20 (t, J = 5.6 Hz, 1H), 6.88 
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(AA'XX', 2H), 4.95 (dd, J = 5.0, 2.6 Hz, 1H), 4.75 (d,
 
J = 5.1 Hz, 1H), 4.69 (s, 1H), 4.58 (dd, J = 14.8, 
6.4 Hz, 1H), 4.38 (dd, J = 14.8, 5.4 Hz, 1H), 3.79 (s 3H), 3.56 (s, 3H); 
13
C NMR (75 MHz, CDCl3, 
25°C):  = 171.0, 163.5, 156.7, 137.7, 129.8, 128.6, 127.7, 127.6, 118.9, 114.5, 83.7, 68.8, 60.0, 58.3, 
55.4, 43.2; IR (KBr):  = 3354, 1746, 1656 cm–1; HRMS (ES): calcd (%) for C20H23N2O5
+
 [M+H]
+
: 
371.1601; found: 371.1583. 
Passerini adduct 3d. From 51 mg (0.15 mmol) of aldehyde ()-1c, compound 3d was obtained as a 
mixture of isomers in a syn/anti ratio (55:45). After flash chromatography (diethyl ether) 25 mg (37%) 
of the less polar compound syn-(+)-3d and 20 mg (31%) of the more polar compound anti-(+)-3d were 
obtained. syn-()-3d. Colorless oil; []D 6.5 (c 0.9, CHCl3). 
1
H NMR (300 MHz, CDCl3, 25°C):  = 
7.88 (AA'BB', 2H), 7.77 (AA'BB', 2H), 7.35 (m, 5H), 6.54 (bs, 1H), 5.50 (d,
 
J = 5.4 Hz, 1H), 4.72 (d, J = 
15.2 Hz, 1H), 4.64 (dd, J = 5.5, 3.4 Hz, 1H), 4.31 (d, J = 15.1 Hz, 1H), 4.03 (t, J = 3.9 Hz, 1H), 3.81 (d,
 
J = 4.5 Hz, 1H), 1.27 (s, 9H); 
13
C NMR (75 MHz, CDCl3, 25°C):  = 169.3, 167.9, 164.1, 135.5, 134.7, 
131.5, 129.0, 128.2, 128.0, 124.0, 68.9, 59.3, 56.0, 51.0, 46.4, 28.5; IR (CHCl3):  = 3384, 1760, 1720, 
1670 cm
–1
; HRMS (ES): calcd (%) for C24H26N3O5
+
 [M+H]
+
: 436.1867; found: 436.1867. anti-(+)-3d. 
Colorless oil; []D +18.2 (c 0.6, CHCl3). 
1
H NMR (300 MHz, CDCl3, 25°C):  = 7.87 (AA'BB', 2H), 
7.78 (AA'BB', 2H), 7.36 (m, 5H), 6.21 (bs, 1H), 5.50 (d,
 
J = 5.3 Hz, 1H), 4.75 (d, J = 14.9 Hz, 1H), 4.40 
(t, J = 5.2 Hz, 1H), 4.39 (d, J = 15.3 Hz, 1H), 4.17 (dd, J = 7.8, 5.5 Hz, 1H), 3.76 (d,
 
J = 7.8 Hz, 1H), 
0.95 (s, 9H); 
13
C NMR (75 MHz, CDCl3, 25°C):  = 169.3, 163.7, 134.8, 134.7, 131.6, 129.2, 128.3, 
128.3, 123.9, 68.5, 58.6, 55.5, 50.8, 45.7, 28.1; IR (CHCl3):  = 3382, 1761, 1722, 1668 cm
–1
; HRMS 
(ES): calcd (%) for C24H26N3O5
+
 [M+H]
+
: 436.1867; found: 436.1872. 
Passerini adduct 3e. From 81 mg (0.36 mmol) of aldehyde ()-1e, compound 3e was obtained as a 
mixture of isomers in a syn/anti ratio (70:30). After flash chromatography (n-hexane/ethyl acetate, 3:2) 
78 mg (67%) of the less polar compound syn-(+)-3e and 34 mg (29%) of the more polar compound anti-
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(+)-3e were obtained. syn-(+)-3e. White solid; Mp: 137138°C (n-hexane/ethyl acetate); []D +39.6 (c 
0.5, CHCl3). 
1
H NMR (300 MHz, CDCl3, 25°C):  = 7.34 (m, 2H), 7.10 (m, 3H), 6.70 (bs, 1H), 5.35 (d,
 
J = 5.0 Hz, 1H), 4.59 (dd, J = 5.0, 3.1 Hz, 1H), 4.40 (d, J = 3.1 Hz, 1H), 4.36 (dd, J = 17.8, 2.6 Hz, 1H), 
3.85 (dd, J = 17.7, J = 2.5 Hz, 1H), 2.31 (t,
 
J = 2.5 Hz, 1H), 1.40 (s, 9H); 
13
C NMR (75 MHz, CDCl3, 
25°C):  = 168.7, 164.7, 156.6, 129.9, 123.3, 115.8, 80.8, 76.1, 73.1, 69.4, 58.6, 51.3, 30.9, 28.6; IR 
(KBr):  = 3297, 3384, 1763, 1666 cm–1; HRMS (ES): calcd (%) for C18H23N2O4
+
 [M+H]
+
: 331.1652; 
found: 331.1652. anti-(+)-3e. White solid; Mp: 8890°C (n-hexane/ethyl acetate); []D +86.4 (c 0.8, 
CHCl3). 
1
H NMR (300 MHz, CDCl3, 25°C):  = 7.33 (m, 2H), 7.09 (m, 3H), 6.72 (bs, 1H), 5.37 (d,
 
J = 
5.0 Hz, 1H), 4.60 (dd, J = 4.8, 3.4 Hz, 1H), 4.50 (d, J = 3.1 Hz, 1H), 4.36 (dd, J = 17.8, 2.6 Hz, 1H), 
4.01 (dd, J = 17.7, 2.5 Hz, 1H), 2.33 (t,
 
J = 2.5 Hz, 1H), 1.32 (s, 9H); 
13
C NMR (75 MHz, CDCl3, 
25°C):  = 169.2, 164.8, 156.7, 129.8, 123.3, 115.9, 81.5, 75.9, 73.3, 69.7, 59.1, 51.4, 30.4, 28.5; IR 
(KBr):  = 3295, 3388, 1761, 1660 cm–1; HRMS (ES): calcd (%) for C18H23N2O4
+
 [M+H]
+
: 331.1652; 
found: 331.1665. 
General Procedure for the Organocatalyzed P-3CR of ketones 4. Synthesis of Compounds 5. 
To a solution of ketone 4 (1 mmol) in anhydrous dichloromethane (5 mL), water (1.1 mmol), the 
appropriate isocyanide (1.1 mmol) and phenyl phosphinic acid (0.1 mmol) were sequentially added at 
room temperature under argon atmosphere. The reaction mixture was stirred until complete 
disappearances of the starting material (TLC). Then, the solvent was removed under reduced pressure. 
The residue was purified by flash chromatography eluting with n-hexane/ethyl acetate mixtures. 
Passerini adduct syn-()-5a. From 44 mg (0.15 mmmol) of azetidine-2,3-dione (+)-4a, 50 mg 
(78%) of compound syn-()-5a was obtained as a white solid after purification by flash chromatography 
(n-hexane/ethyl acetate, 2:1).
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Passerini adduct syn-()-5b. From 60 mg (0.22 mmmol) of azetidine-2,3-dione ()-4b, 66 mg 
(80%) of compound syn-()-5b was obtained as a white solid after purification by flash chromatography 
(n-hexane/ethyl acetate, 1:1). Mp: 148149°C (n-hexane/ethyl acetate); []D 79.7 (c 2.0, CHCl3); 
1
H 
NMR (300 MHz, CDCl3, 25°C):  = 7.44 (m, 2H), 7.30 (m, 8H), 6.89 (t, J = 5.8 Hz, 1H), 5.47 (bs, 1H), 
5.02 (d, J = 15.2 Hz, 1H), 4.48 (dd, J =14.8, 6.1 Hz, 1H), 4.36 (m, 2H), 4.24 (d, J = 15.1 Hz, 1H), 4.10 
(dd, J = 9.1, 7.2 Hz, 1H), 3.94 (d, J = 5.3 Hz, 1H), 3.64 (dd, J =9.1, 4.4 Hz, 1H), 1.41 (s, 3H), 1.34 (s, 
3H); 
13
C NMR (75 MHz, CDCl3, 25°C):  = 167.4, 167.3, 137.4, 134.3, 128.74, 128.69, 128.4, 127.8, 
127.6, 127.5, 110.3, 85.2, 75.1, 66.3, 63.6, 45.5, 43.3, 26.3, 24.9; IR (KBr):  = 3315, 1745, 1671 cm–1; 
HRMS (ES): calcd (%) for C23H27N2O5
+
 [M+H]
+
: 411.1914; found: 411.1930. 
Passerini adduct syn-()-5c. From 32 mg (0.11 mmmol) of azetidine-2,3-dione (+)-4a, 21 mg 
(48%) of compound syn-()-5c was obtained as a white solid after purification by flash chromatography 
(n-hexane/ethyl acetate, 1:1). Mp: 154156°C (n-hexane/ethyl acetate); []D 7.0 (c 0.6, CHCl3); 
1
H 
NMR (300 MHz, CDCl3, 25°C):  = 7.49 (AA'XX', 2H), 6.86 (AA'XX', 2H), 6.56 (bs, 1H), 5.08 (bs, 
1H), 4.60 (d, J = 4.8 Hz, 1H), 4.43 (td, J = 6.7, 4.9 Hz, 1H), 4.20 (dd, J =8.9, 6.7 Hz, 1H), 3.79 (s, 3H), 
3.80 (dd, J = 8.8, 6.9 Hz, 1H), 1.41 (s, 3H), 1.39 (s, 9H), 1.37 (s, 3H); 
13
C NMR (75 MHz, CDCl3, 
25°C):  = 166.0, 164.7, 157.1, 130.0, 120.6, 114.0, 110.2, 84.9, 75.7, 66.5, 64.9, 55.4, 51.7, 28.6, 26.3, 
25.2; IR (KBr):  = 3243, 1759, 1658 cm–1; HRMS (ES): calcd (%) for C20H29N2O6
+
 [M+H]
+
: 
393.2020; found: 393.2034. 
Passerini adduct syn-()-5d. From 55 mg (0.24 mmmol) of azetidine-2,3-dione ()-4c, 56 mg 
(71%) of compound syn-()-5d was obtained as a white solid after purification by flash chromatography 
(n-hexane/ethyl acetate, 1:1). Mp: 130132°C (n-hexane/ethyl acetate) []D 106.8(c 0.3, CHCl3); 
1
H 
NMR (300 MHz, CDCl3, 25°C):  = 6.57 (bs, 1H), 5.85 (m, 1H), 5.36 (m, 2H), 4.96 (bs, 1H), 4.34 (m, 
2H), 4.17 (dd, J = 8.9, 7.2 Hz, 1H), 4.05 (d, J = 4.5 Hz, 1H), 3.82 (dd, J = 9.1, 4.5 Hz, 1H), 3.70 (dd, J 
28 
 
 
=15.7, 7.5 Hz, 1H), 1.39 (s, 9H), 1.38 (s, 3H), 1.36 (s, 3H); 
13
C NMR (75 MHz, CDCl3, 25°C):  = 
167.4, 166.1, 130.9, 119.1, 110.2, 85.3, 75.2, 66.4, 63.7, 51.4, 44.1, 28.6, 26.5, 25.0; IR (KBr):  = 
3403, 1746, 1679 cm
–1
; HRMS (ES): calcd (%) for C16H27N2O5
+
 [M+H]
+
: 327.1914; found: 327.1914. 
Passerini adduct syn-()-5e. From 42 mg (0.14 mmmol) of azetidine-2,3-dione ()-4a, 27 mg 
(45%) of compound syn-()-5e was obtained as a white solid after purification by flash chromatography 
(n-hexane/ethyl acetate, 1:1). Mp: 123124°C (n-hexane/ethyl acetate); []D +5.8 (c 0.2, CHCl3). 
1
H 
NMR (300 MHz, CDCl3, 25°C):  = 7.57 (AA'XX', 2H), 6.87 (AA'XX', 2H), 6.37 (bs, 1H), 4.56 (d, J = 
6.6 Hz, 1H), 4.45 (q, J = 6.6 Hz, 1H), 4.20 (q, J = 7.0 Hz, 2H), 4.22 (m, 2H), 3.96 (dd, J = 18.0, 5.0 Hz, 
1H), 3.80 (s, 3H), 3.79 (m, 1H), 1.46 (s, 3H), 1.38 (s, 3H), 1.28 (t, J = 7.2 Hz, 3H); 
13
C NMR (75 MHz, 
CDCl3, 25°C):  = 170.1, 167.9, 164.5, 157.2, 130.0, 120.7, 114.0, 110.1, 84.1, 76.3, 66.7, 66.3, 61.7, 
55.4, 41.1, 26.5, 25.1, 14.0; IR (KBr):  = 3346, 1750, 1680 cm–1; HRMS (ES): calcd (%) for 
C20H30N3O8
+
 [M+H]
+
: 440.2027; found: 440.2045. 
General Procedure for the Ring Expansion of Ugi Adducts 2. Synthesis of functionalized -
lactams 6. Method A. To a solution of Ugi adduct 2 (1 mmol) in methanol (23 mL), sodium methoxide 
(1 mmol), was added in small portions at room temperature under argon atmosphere. The reaction 
mixture was stirred until complete disappearances of the starting material (TLC). Then, the solvent was 
removed under reduced pressure. The residue was purified by flash chromatography eluting with n-
hexane/ethyl acetate mixtures. Method B. To a solution of Ugi adduct syn-(+)-2a (1 mmol) in methanol 
(2 mL), sulfuric acid (cc.) (12 mL) was added at room temperature. The reaction mixture was dtirred for 
54 h. Then, the mixture was neutralized with NaHCO3 (sat.) (50 mL). The methanol was removed under 
reduced pressure and the mixture was extracted with ethyl acetate (5 x 100 mL). The organic layer was 
dried (MgSO4) and concentrated under reduced pressure. The residue was purified by flash 
chromatography eluting with n-hexane/ethyl acetate mixtures. 
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Functionalized -lactam syn-(+)-6a. Method A. From 46 mg (0.11 mmmol) of compound syn-()-
2a, 39 mg (84%) of compound syn-()-6a was obtained as a colorless oil after purification by flash 
chromatography (n-hexane/ethyl acetate, 1:3). Method B. From 51 mg (0.12 mmmol) of compound 
syn-()-2a, 11 mg (22%) of compound syn-()-6a was obtained as a colorless oil after purification by 
flash chromatography (n-hexane/ethyl acetate, 1:3). []D +155.8 (c 0.3, CHCl3); 
1
H NMR (300 MHz, 
CDCl3, 25°C):  =7.82 (bs, 1H), 7.22 (m, 3H), 7.11 (m, 2H), 6.79 (AA'BB', 2H), 6.75 (AA'BB', 2H), 
5.78 (m, 1H), 5.20 (m, 2H), 4.58 (d,
 
J = 7.4 Hz, 1H), 4.44 (dd, J = 15.2, 6.4 Hz, 1H), 4.32 (d,
 
J = 9.1 Hz, 
1H), 4.27 (dd, J =15.2, 5.3 Hz, 1H), 4.18 (dd, J = 9.0, 7.3 Hz, 1H), 4.15 (m, 1H), 3.73 (s, 3H), 3.63 (s, 
3H), 3.58 (dd J = 15.7, 6.9 Hz, 1H); 
13
C NMR (75 MHz, CDCl3, 25°C):  = 171.3, 168.3, 152.8, 140.2, 
136.9, 131.7, 128.7, 127.8, 127.7, 119.3, 115.1, 114.4, 81.1, 61.1, 59.2, 57.5, 55.6, 45.0, 43.9; IR 
(CHCl3):  = 3317, 1689 cm
–1
; HRMS (ES): calcd (%) for C23H28N3O4
+
 [M+H]
+
: 410.2074; found: 
410.2067. 
Functionalized-lactam anti-()-6a. Method A. From 44 mg (0.11 mmmol) of compound anti-
()-2a, 27 mg (60%) of compound anti-()-6a was obtained as a white solid after purification by flash 
chromatography (n-hexane/ethyl acetate, 1:3). Mp: 163165°C (n-hexane/ethyl acetate); []D 9.2(c 
0.3, CHCl3); 
1
H NMR (300 MHz, CDCl3, 25°C):  = 8.01 (bs, 1H), 7.26 (m, 5H), 6.78 (AA'BB', 2H), 
6.73 (AA'BB', 2H), 5.74 (m, 1H), 5.15 (m, 2H), 4.49 (dd, J = 14.9, 6.1 Hz, 1H), 4.39 (m, 1H), 4.36 (dd, 
J =14.8, 5.9 Hz, 1H), 4.09 (t, J = 5.7 Hz, 1H), 4.03 (d,
 
J = 5.4 Hz, 1H), 3.94 (d,
 
J = 6.1 Hz, 1H), 3.74 (s, 
3H), 3.56 (s, 3H), 3.44 (dd, J = 15.5, 7.4 Hz, 1H), 2.91 (bs, 1H); 
13
C NMR (75 MHz, CDCl3, 25°C):  = 
171.1, 168.9, 153.5, 138.9, 137.4, 130.8, 128.7, 127.8, 127.7, 119.9, 115.8, 115.0, 83.1, 65.9, 58.7, 58.3, 
55.6, 44.5, 43.7; IR (KBr):  = 3364, 3277, 1699, 1657 cm–1; HRMS (ES): calcd (%) for C23H28N3O4
+
 
[M+H]
+
: 410.2074; found: 410.2077. 
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Functionalized-lactam syn-()-6b. Method A. From 31 mg (0.08 mmmol) of compound syn-()-
2b, 25 mg (82%) of compound syn-()-6b was obtained as a colorless oil after purification by flash 
chromatography (n-hexane/ethyl acetate, 1:3). []D +139.6 (c 0.2, CHCl3); 
1
H NMR (300 MHz, d
6
-
acetone, 25°C):  = 6.80 (AA'BB', 2H), 6.74 (AA'BB', 2H), 5.77 (m, 1H), 5.21 (m, 2H), 4.45 (d, J = 7.3 
Hz, 1H), 4.25 (d, J = 8.8 Hz, 1H), 4.11 (m, 1H), 4.07 (ddt, J = 15.2, 5.5 Hz,
 
1.5 Hz, 1H), 3.72 (s, 3H), 
3.62 (s, 3H), 3.59 (dd, J = 15.6, 6.4 Hz, 1H), 1.19 (s, 9H); 
13
C NMR (75 MHz, CDCl3, 25°C):  = 171.3, 
167.3, 152.8, 140.3, 132.1, 119.2, 115.2, 114.4, 81.0, 61.5, 59.2, 57.2, 55.8, 52.0, 45.0, 28.3; IR 
(CHCl3):  = 3337, 1689 cm
–1
; HRMS (ES): calcd (%) for C20H29N3O4
+
 [M+H]
+
: 376.2231; found: 
376.2235. 
Functionalized -lactam anti-()-6b. From 21 mg (0.06 mmmol) of compound anti-()-2b, 15 mg 
(71%) of compound anti-()-6b was obtained as a colorless oil after purification by flash 
chromatography (n-hexane/ethyl acetate, 1:3); []D 14.1 (c 1.2, CHCl3); 
1
H NMR (300 MHz, CD3OD, 
25°C):  = 6.77 (AA'BB', 2H), 6.68 (AA'BB', 2H), 5.76 (m, 1H), 5.23 (m, 2H), 4.38 (ddt, J = 15.4, 4.8 
Hz, 1.5 Hz, 1H), 4.04 (m, 2H), 3.84 (d, J = 6.0 Hz, 1H), 3.72 (s, 3H), 3.59 (s, 3H), 3.39 (dd, J = 15.3, 
7.7 Hz, 1H), 1.24 (s, 9H); 
13
C NMR (75 MHz, CDCl3, 25°C):  = 171.0, 168.1, 153.2, 139.7, 131.2, 
119.7, 115.6, 115.0, 83.1, 66.6, 58.52, 58.48, 55.7, 51.6, 44.5, 28.4; IR (CHCl3):  = 3334, 1693 cm
–1
; 
HRMS (ES): calcd (%) for C20H29N3O4
+
 [M+H]
+
: 376.2231; found: 376.2234. 
Functionalized -lactam syn-()-6c. From 32 mg (0.08 mmmol) of compound syn-()-2c, 26 mg 
(81%) of compound syn-()-6c was obtained as a colorless oil after purification by flash 
chromatography (dichloromethane/ethyl acetate, 5:1); []D +149.7 (c 0.5, CHCl3); 
1
H NMR (300 MHz, 
CDCl3, 25°C):  = 7.32 (m, 7H), 7.14 (dd, J = 8.7, 1.0 Hz, 2H), 7.01 (tt, J = 7.2, 1.0 Hz, 1H), 6.52 (t, J = 
5.3 Hz, 1H), 5.74 (m, 2H), 5.12 (d,
 
J = 9.1 Hz, 1H), 5.13 (m, 4H), 4.49 (d, J = 5.8 Hz, 2H), 4.31 (ddt, J 
= 15.1, 5.3, 1.4 Hz, 1H), 4.04 (d,
 
J = 7.9 Hz, 1H), 3.74 (dd, J = 8.6, 8.0 Hz, 1H), 3.58 (dd, J = 15.3, 7.9 
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Hz, 1H), 3.37 (ddt, J = 14.0, 5.7, 1.4 Hz, 1H), 3.30 (ddt, J = 14.0, 5.7, 1.4 Hz, 1H); 
13
C NMR (75 MHz, 
CDCl3, 25°C):  = 171.0, 168.7, 158.4, 137.4, 135.8, 131.6, 129.4, 128.8, 127.9, 127.8, 122.0, 119.3, 
116.5, 80.9, 61.4, 60.7, 50.6, 45.0, 43.8; IR (CHCl3):  = 3308, 1688 cm
–1
; HRMS (ES): calcd (%) for 
C24H28N3O3
+
 [M+H]
+
: 406.2125; found: 406.2125. 
Functionalized -lactam anti-()-6c. From 15 mg (0.04 mmmol) of compound anti-()-2c, 11 mg 
(76%) of compound anti-()-6c was obtained as a colorless oil after purification by flash 
chromatography (n-hexane/ethyl acetate, 1:2); []D +10.2 (c 0.4, CHCl3); 
1
H NMR (300 MHz, CDCl3, 
25°C):  = 7.30 (m, 7H), 7.01 (m, 3H), 6.66 (bs, 1H), 5.75 (m, 2H), 5.16 (m, 4H), 4.62 (d, J = 4.3 Hz, 
1H), 4.47 (d, J = 5.9 Hz, 2H), 4.43 (m, 1H), 3.87 (d,
 
J = 4.5 Hz,1H), 3.68 (dd, J = 15.2, 7.8 Hz, 1H), 
3.58 (t, J = 4.3 Hz, 1H), 3.31 (d, J = 5.9 Hz, 2H); 
13
C NMR (75 MHz, CDCl3, 25°C):  = 170.7, 169.0, 
157.6, 137.5, 135.2, 130.8, 129.5, 128.8, 127.9, 127.8, 122.3, 119.9, 117.1, 116.2, 81.2, 64.6, 61.4, 49.8, 
44.9, 43.6; IR (CHCl3):  = 3285, 1700, 1660 cm
–1
; HRMS (ES): calcd (%) for C24H28N3O3
+
 [M+H]
+
: 
406.2125; found: 406.2138. 
Functionalized-lactams syn-()-6d and anti-(+)-6d. Method B. From 72 mg (0.16 mmol) of an 
inseparable mixture (64:36) of compound 2e, compound 6d was obtained as a mixture of isomers in a 
syn/anti ratio (64:36). After flash chromatography (dichloromethane/ethyl acetate, 2:1) 31 mg (51%) of 
the less polar compound syn-(+)-6d and 21 mg (28%) of the more polar compound anti-(+)-6d were 
obtained. syn-()-6d. Colorless oil; []D +91.9 (c 0.3, CHCl3); 
1
H NMR (300 MHz, CDCl3, 25°C):  = 
7.29 (AA'XX', 2H), 6.86 (AA'XX', 2H), 6.81 (AA'BB', 2H), 6.65 (AA'BB', 2H), 5.29 (bs, 1H), 4.42 (d, J 
= 7.0 Hz, 1H), 4.39 (d, J = 8.3 Hz, 1H), 4.30 (m, 1H), 3.78 (s, 3H), 3.75 (s, 3H), 3.72 (s, 3H), 1.15 (s, 
9H); 
13
C NMR (75 MHz, CDCl3, 25°C):  = 170.8, 167.5, 158.0, 152.8, 140.1, 130.7, 124.8, 115.2, 
114.4, 114.3, 80.9, 64.5, 59.4, 57.2, 55.8, 55.4, 52.0, 28.2; IR (CHCl3):  = 3340, 1692 cm
–1
; HRMS 
(ES): calcd (%) for C24H31N3O5
+
 [M+H]
+
: 442.2336; found: 442.2332. anti-()-6d. Brown solid; Mp: 
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8587°C (n-hexane/ethyl acetate); []D 3); 
1
H NMR (300 MHz, CDCl3, 25°C):  = 
7.38 (AA'XX', 2H), 6.85 (AA'XX', 2H), 6.79 (bs, 4H), 6.06 (bs, 1H), 4.30 (d, J = 3.2 Hz, 1H), 4.09 (bs, 
1H), 3.90 (d, J = 3.6 Hz, 1H), 3.76 (s, 3H), 3.75 (s, 3H), 3.62 (s 3H), 1.19 (s, 9H); 
13
C NMR (75 MHz, 
CDCl3, 25°C):  = 170.3, 168.0, 157.7, 153.3, 139.2, 130.0, 123.6, 115.7, 115.0, 114.2, 83.6, 68.4, 58.7, 
58.1, 55.6, 55.4, 51.5, 28.3; IR (KBr):  = 3340, 1696 cm–1; HRMS (ES): calcd (%) for C24H31N3O5
+
 
[M+H]
+
: 442.2336; found: 442.2341. 
Functionalized-lactam syn-()-6e. From 38 mg (0.08 mmmol) of compound syn-()-2f, 17 mg 
(45%) of compound syn-()-6e was obtained as a yellow oil after purification by flash chromatography 
(n-hexane/ethyl acetate, 1:1); []D +151.1 (c 2.0, CHCl3); 
1
H NMR (300 MHz, CDCl3, 25°C):  = 8.24 
(AA'XX', 2H), 7.78 (AA'XX', 2H), 7.32 (m, 2H), 7.16 (d, J = 7.8 Hz, 2H), 7.05 (t, J = 7.3 Hz, 1H), 6.04 
(bs, 1H), 5.88 (m, 1H), 5.23 (d, J = 9.5 Hz, 1H), 5.21 (m, 2H), 4.46 (d, J = 7.9 Hz, 1H), 3.86 (dd, J = 
9.4, 7.9 Hz, 1H), 3.50 (dd, J = 14.3, 5.7 Hz, 1H), 3.41 (dd, J = 14.3, 5.7 Hz, 1H), 1.40 (s, 9H); 
13
C NMR 
(75 MHz, CDCl3, 25°C):  = 171.1, 167.0, 158.2, 144.2, 143.7, 135.7, 129.5, 124.7, 122.4, 120.2, 116.6, 
116.3, 80.6, 63.4, 60.2, 52.6, 50.7, 28.6; IR (CHCl3):  = 3347, 1718 cm
–1
; HRMS (ES): calcd (%) for 
C24H28N4O5
+
 [M+H]
+
: 453.2132; found: 453.2149. 
Reaction of -hydroxy amide syn-(+)-3a with FeCl3·6H2O. To a solution of -hydroxy amide 
syn-(+)-3a (51 mg, 0.15 mmol) in anhydrous 1,2-dichloroethane (1.5 mL), FeCl3 (0.10 mmol) was 
added. The resulting mixture was heated at 85°C for 21 h. The reaction mixture was allowed to cool to 
room temperature, and then quenched with NH4Cl sat. (0.15 mL). The mixture was extracted with ethyl 
acetate (3 x 4 mL), and the combined extracts were washed with brine. The organic layer was dried 
(MgSO4) and concentrated under reduced pressure. The residue was purified by flash chromatography 
eluting with n-hexane/ethyl acetate (1:1) affording 12 mg (23%) of -lactone syn-(+)-7a as a colorless 
solid. 
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Reaction of -hydroxy amide syn-(+)-3a in acidic conditions. To a solution of -hydroxy amide 
syn-(+)-3a (39 mg, 0.12 mmol) in methanol (2.7 mL), sulphuric acid cc. (1.4 mL) was slowly added. 
The resulting mixture was stirred at room temperature for 2 hours. Then, NaHCO3 (cc.) (6 mL) was 
added until pH = 7. The methanol was removed under reduced pressure and the mixture was extracted 
with ethyl acetate (5 x 12 mL). The organic layer was dried (MgSO4) and concentrated under reduced 
pressure. Chromatogaphy of the residue eluting with n-hexane/ethyl acetate (1:1) gave analytically pure 
amino ester ()-8 (32 mg, 73%). 
Reaction of -hydroxy amide syn-(+)-3a in basic conditions. To a solution of -hydroxy amide 
syn-(+)-3a (21 mg, 0.06 mmol) in methanol (1.43 mL), sodium methoxide (3 mg, 0.06 mmol) was 
added in small portions at room temperature and under argon atmosphere. The reaction mixture was 
stirred for 6h. After disappearance of the starting material (TLC) the solvent was removed under 
reduced pressure. Chromatography of the residue gave analytically eluting with n-hexane/ethyl acetate 
(1:1) gave analytically pure amino ester ()-8 (11 mg, 47%) and -lactone syn-(+)-7a (7 mg, 32%). 
General Procedure for the Synthesis of functionalized -lactones 7. To a solution of -hydroxy 
amide 3 (1 mmol) in methanol (23 mL), sulphuric acid cc (12 mL) was slowly added. The resulting 
mixture was stirred at room temperature until complete disappearance (TLC) of the starting material. 
Then, NaHCO3 (cc.) (50 mL) was added until pH = 7. The methanol was removed under reduced 
pressure and the mixture was extracted with ethyl acetate (5 x 100 mL). The organic layer was dried 
(MgSO4) and concentrated under reduced pressure. To a stirred solution of the crude mixture in 
anhydrous toluene (25 mL), p-toluensulfonic acid (0.2 mmol) was added. The reaction mixture was 
stirred at reflux temperature for 2h. Then, NaHCO3 (cc.) (10 mL) was added and was extracted with 
ethyl acetate (3 x 20 mL). The organic layer was dried (MgSO4) and concentrated under reduced 
pressure. Chromatography of the residue gave analytically pure compounds 7. 
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Functionalized-lactone, syn-()-7a. From 31 mg (0.09 mmmol) of compound syn-()-3a, 23 mg 
(73%) of compound syn-()-7a was obtained as a colorless solid after purification by flash 
chromatography (n-hexane/ethyl acetate, 1:1); Mp: 143145°C (n-hexane/ethyl acetate); []D +51.1 (c 
0.4, CHCl3); 
1
H NMR (300 MHz, CDCl3, 25°C):  = 6.84 (AA'XX', 2H), 6.75 (AA'XX', 2H), 5.92 (bs, 
1H), 4.95 (d, J = 6.7 Hz, 1H), 4.30 (t,
 
J = 6.5 Hz, 1H), 4.20 (d, J = 6.4 Hz, 1H), 3.77 (s, 3H), 3.63 (s, 
3H), 1.35 (s, 9H); 
13
C NMR (75 MHz, CDCl3, 25°C):  = 172.1, 165.8, 153.5, 139.6, 115.6, 115.0, 79.2, 
77.2, 59.1, 58.8, 55.7, 52.3, 28.5; IR (KBr):  = 3363, 1790, 1679 cm–1; HRMS (ES): calcd (%) for 
C17H25N2O5
+
 [M+H]
+
: 337.1758; found: 337.1752. 
Functionalized-lactone, anti-()-7a. From 29 mg (0.09 mmmol) of compound anti-()-3a, 10 mg 
(34%) of compound anti-()-7a was obtained as a colorless oil after purification by flash 
chromatography (n-hexane/ethyl acetate, 1:1); []D +20.6 (c 0.4, CHCl3); 
1
H NMR (300 MHz, CDCl3, 
25°C):  = 6.87 (AA'XX', 2H), 6.82 (AA'XX', 2H), 6.10 (bs, 1H), 4.55 (d, J = 5.4 Hz, 1H), 4.15 (t, J = 
5.1 Hz, 1H), 3.93 (d, J = 5.1 Hz, 1H), 3.77 (s, 3H), 3.62 (s, 3H), 1.37 (s, 9H); 
13
C NMR (75 MHz, 
CDCl3, 25°C):  = 171.9, 166.6, 154.0, 139.0, 117.0, 114.8, 81.3, 78.2, 61.0, 58.9, 55.6, 51.8, 28.6; IR 
(CHCl3):  = 3344, 1792, 1672 cm
–1
; HRMS (ES): calcd (%) for C17H25N2O5
+
 [M+H]
+
: 337.1758; 
found: 337.1758. 
Functionalized-lactone, syn-()-7b. From 28 mg (0.08 mmmol) of compound syn-()-3b, 13 mg 
(47%) of compound syn-()-7b was obtained as a colorless oil after purification by flash 
chromatography (n-hexane/ethyl acetate, 1:2); []D +70.5 (c 0.4, CHCl3); 
1
H NMR (300 MHz, CDCl3, 
25°C):  = 7.33 (m, 3H), 7.19 (m, 2H), 6.79 (AA'XX', 2H), 6.62 (AA'XX', 2H), 6.54 (t, J = 5.6 Hz, 1H), 
5.06 (d, J = 6.6 Hz, 1H), 4.46 (d, J = 5.8 Hz, 2H), 4.33 (t,
 
J = 6.3 Hz, 1H), 4.12 (d, J = 6.0 Hz, 1H), 3.76 
(s, 3H), 3.63 (s, 3H); 
13
C NMR (75 MHz, CDCl3, 25°C):  = 171.9, 166.5, 153.5, 139.3, 136.8, 128.9, 
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127.9, 127.8, 115.7, 115.0, 79.2, 77.3, 59.1, 58.9, 55.6, 43.6; IR (CHCl3):  = 3358, 1790, 1673 cm
–1
; 
HRMS (ES): calcd (%) for C20H23N2O5
+
 [M+H]
+
: 371.1601; found: 371.1598. 
Functionalized-lactone, anti-()-7b. From 40 mg (0.11 mmmol) of compound anti-()-3b, 17 mg 
(42%) of compound anti-()-3b was obtained as a white solid after purification by flash 
chromatography (n-hexane/ethyl acetate, 1:1); Mp: 161163°C (n-hexane/ethyl acetate); []D10.6 (c 
0.5, CHCl3); 
1
H NMR (300 MHz, CDCl3, 25°C):  = 7.31 (m, 5H), 6.86 (AA'XX', 2H), 6.83 (AA'XX', 
2H), 6.70 (t,
 
J = 5.4 Hz, 1H), 4.71 (d, J = 4.9 Hz, 1H), 4.55 (dd, J = 14.8, 6.2 Hz, 1H), 4.42 (dd, J = 
14.7, 5.7 Hz, 1H), 4.24 (t, J = 4.7 Hz, 1H), 3.90 (d, J = 4.7 Hz, 1H), 3.77 (s, 3H), 3.57 (s, 3H); 
13
C NMR 
(75 MHz, CDCl3, 25°C):  = 171.8, 167.4, 154.0, 138.9, 137.0, 128.8, 127.81, 127.77, 116.9, 114.9, 
81.0, 78.8, 60.9, 58.9, 55.6, 43.2; IR (KBr):  = 3341, 1793, 1667 cm–1; HRMS (ES): calcd (%) for 
C20H23N2O5
+
 [M+H]
+
: 371.1601; found: 371.1598. 
Functionalized-lactone, syn-()-7c. From 26 mg (0.07 mmmol) of compound syn-()-3c, 15 mg 
(57%) of compound syn-()-7c was obtained as a colorless oil after purification by flash 
chromatography (n-hexane/ethyl acetate, 1:1); []D +87.1 (c 0.7, CHCl3); 
1
H NMR (300 MHz, CDCl3, 
25°C):  = 7.30 (m, 2H), 7.06 (m, 3H), 6.80 (AA'XX', 2H), 6.67 (AA'XX', 2H), 5.86 (bs, 1H), 5.11 (d, J 
= 6.9 Hz, 1H), 5.03 (d, J = 6.6 Hz, 1H), 4.57 (t,
 
J = 6.7 Hz, 1H), 4.06 (bs, 1H), 3.76 (s, 3H), 1.34 (s, 
9H); 
13
C NMR (75 MHz, CDCl3, 25°C):  = 171.2, 165.7, 157.6, 153.6, 139.3, 129.6, 122.9, 116.6, 
115.7, 115.0, 77.2, 77.3, 59.0, 55.7, 52.4, 28.4; IR (CHCl3):  = 3371, 1791, 1680 cm
–1
; HRMS (ES): 
calcd (%) for C22H27N2O5
+
 [M+H]
+
: 399.1914; found: 399.1922. 
Functionalized-lactone, syn-()-7d. From 35 mg (0.11 mmmol) of compound syn-()-3d, 18 mg 
(52%) of compound syn-()-7d was obtained as a colorless oil after purification by flash 
chromatography (n-hexane/ethyl acetate, 1:1); []D +73.3 (c 0.6, CHCl3); 
1
H NMR (300 MHz, CDCl3, 
25°C):  = 7.32 (m, 2H), 7.08 (m, 3H), 6.22 (bs, 1H), 5.05 (d, J = 5.7 Hz, 1H), 4.95 (d, J = 4.1 Hz, 1H), 
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4.12 (dd,
 
J = 5.7, 4.1 Hz, 1H), 3.60 (dd, J = 17.5, 2.4 Hz, 1H), 3.46 (dd, J = 17.5, 2.4 Hz, 1H), 2.28 (t,
 
J 
= 2.4 Hz, 1H), 1.41 (s, 9H); 
13
C NMR (75 MHz, CDCl3, 25°C):  = 171.1, 165.6, 157.1, 129.6, 116.2, 
80.7, 78.8, 77.0, 73.0, 60.5, 52.3, 36.5, 28.6; IR (CHCl3):  = 3301, 1789, 1674 cm
–1
; HRMS (ES): 
calcd (%) for C18H23N2O4
+
 [M+H]
+
: 331.1652; found: 331.1643. 
Hydroxy amino ester ()-8. Colorless oil. []D 6.0(c 2.0, CHCl3); 
1
H NMR (300 MHz, CDCl3, 
25°C):  = 6.75 (AA'XX', 2H), 6.68 (AA'XX', 2H), 6.44 (bs, 1H), 4.29 (d, J = 2.3 Hz, 1H), 4.21 (d, J = 
4.2 Hz, 1H), 4.17 (dd,
 
J = 4.1, 2.5 Hz, 1H,), 3.73 (s, 3H), 3.51 (s, 3H), 3.50 (s, 3H), 1.29 (s, 9H); 
13
C 
NMR (75 MHz, CDCl3, 25°C):  = 170.8, 170.2, 153.2, 140.3, 116.3, 114.6, 80.2, 71.1, 59.7, 58.9, 55.6, 
51.9, 51.0, 28.5; IR (CHCl3):  = 3391, 1746, 1659 cm
–1
; HRMS (ES): calcd (%) for C18H29N2O6
+
 
[M+H]
+
: 369.2020; found: 369.2012. 
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